ACELRX PHARMACEUTICALS INC
New Filing
CIK: 0001427925·Biotechnology·DELAWARE·Filed: Jul 13, 2011
Total Offering
$20,839,994
Amount Sold
$20,839,994
Investors
2
First Sale
Jun 29, 2011
Offering Details
- Type
- Debt, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Richard King | Related Person |
| Pamela P. Palmer | Related Person |
| Hamel G. Lawrence | Related Person |
| Badri N. Dasu | Related Person |
| James H. Welch | Related Person |
| Thomas Schreck | Related Person |
| Stephen J. Hoffman | Related Person |
| Guy Nohra | Related Person |
| Howard B. Rosen | Related Person |
| Mark Wan | Related Person |
Company
SEC Filing
0001427925-11-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free